Related Experiment Video
Updated: Oct 30, 2025

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical
Alexander Malogolovkin1, Nizami Gasanov1, Alexander Egorov1
1Gene Therapy Department, Sirius University of Science and Technology, Olympic Avenue, 1, 354340 Sochi, Russia.
Cancer immunotherapy, including immune checkpoint inhibitors (ICI) and oncolytic viruses, offers new hope. This review highlights effective combinations of oncolytic viruses with other therapies for cancer treatment.
Area of Science:
- Oncology
- Immunotherapy
- Virology
Background:
- Cancer immunotherapy has advanced significantly, with immune checkpoint inhibitors (ICI) becoming crucial in treating various cancers.
- Oncolytic viruses are emerging as a promising therapeutic strategy, showing encouraging results in clinical trials.
- Combining oncolytic viruses with conventional treatments like chemotherapy and radiotherapy is under extensive investigation.
Purpose of the Study:
- To review clinical trial data on oncolytic viruses, focusing on their efficacy and safety.
- To identify and highlight the most promising combinations of oncolytic viruses with other immunotherapies and treatments.
- To provide insights into future strategies for cancer treatment using virus immunotherapy.
Main Methods:
- Systematic review of published clinical trial data on oncolytic virus therapy.
- Analysis of combinations involving oncolytic viruses with immune checkpoint blockade, cytokines, antigens, and other oncolytic viruses.
- Evaluation of efficacy and safety data from clinical studies.
Main Results:
- Oncolytic viruses, with or without genetic modifications, show potential when combined with immune checkpoint blockade and other agents.
- Several combinations are demonstrating encouraging outcomes in clinical settings.
- The review focuses on published clinical data to identify effective therapeutic strategies.
Conclusions:
- Virotherapy, particularly in combination with other immunotherapies, represents a significant advancement in cancer treatment.
- Further research into optimizing oncolytic virus combinations is essential for maximizing therapeutic benefits.
- Future perspectives suggest novel strategies for cancer treatment through advanced virus immunotherapy.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

